Book contents
- Treatment of Dystonia
- Treatment of Dystonia
- Copyright page
- Contents
- Contributors
- Preface
- 1 Development of the Concept of Dystonia as a Disease, a Syndrome and a Movement Phenomenology
- Section I Basics
- 2 Classification of Dystonia
- 3 Primary or Idiopathic Dystonias (‘Isolated Dystonia’)
- 4 Non-Primary Dystonias
- 5 Epidemiology of Dystonia
- 6 The Motor Network Model for Dystonia
- 7 Functional Imaging in Dystonia
- 8 The Pathophysiology of Dystonia
- 9 Animal Models of Dystonia
- 10 Genetics of the Dystonias
- 11 Dystonia
- 12 Dystonia and Tremor
- 13 Posttraumatic Dystonia
- 14 Non-Motor Symptoms in Dystonia
- 15 Scales for Assessment of Dystonia
- 16 Theories Behind Dystonia Scale Development
- 17 Linking Allied Health Professionals and Physicians
- 18 The Role and Responsibility of the Dystonia Specialist Nurse
- 19 History of Dystonia Treatments
- 20 Dystonia in Arts and Artists
- Section II Botulinum Toxin Therapy
- Section III Musician’s Dystonia
- Section IV Psychogenic Dystonia
- Section V Treatment of Paediatric Dystonia
- Section VI Rehabilitation of Dystonia
- Section VII Pharmacotherapy for Dystonia
- Section VIII Surgical Treatment of Dystonia
- Section IX Deep Brain Stimulation for Dystonia
- Section X Emerging Therapies for Dystonia
- Section XI Future Trends in Dystonia Therapy
- Book part
- Index
- References
15 - Scales for Assessment of Dystonia
from Section I - Basics
Published online by Cambridge University Press: 31 May 2018
Book contents
- Treatment of Dystonia
- Treatment of Dystonia
- Copyright page
- Contents
- Contributors
- Preface
- 1 Development of the Concept of Dystonia as a Disease, a Syndrome and a Movement Phenomenology
- Section I Basics
- 2 Classification of Dystonia
- 3 Primary or Idiopathic Dystonias (‘Isolated Dystonia’)
- 4 Non-Primary Dystonias
- 5 Epidemiology of Dystonia
- 6 The Motor Network Model for Dystonia
- 7 Functional Imaging in Dystonia
- 8 The Pathophysiology of Dystonia
- 9 Animal Models of Dystonia
- 10 Genetics of the Dystonias
- 11 Dystonia
- 12 Dystonia and Tremor
- 13 Posttraumatic Dystonia
- 14 Non-Motor Symptoms in Dystonia
- 15 Scales for Assessment of Dystonia
- 16 Theories Behind Dystonia Scale Development
- 17 Linking Allied Health Professionals and Physicians
- 18 The Role and Responsibility of the Dystonia Specialist Nurse
- 19 History of Dystonia Treatments
- 20 Dystonia in Arts and Artists
- Section II Botulinum Toxin Therapy
- Section III Musician’s Dystonia
- Section IV Psychogenic Dystonia
- Section V Treatment of Paediatric Dystonia
- Section VI Rehabilitation of Dystonia
- Section VII Pharmacotherapy for Dystonia
- Section VIII Surgical Treatment of Dystonia
- Section IX Deep Brain Stimulation for Dystonia
- Section X Emerging Therapies for Dystonia
- Section XI Future Trends in Dystonia Therapy
- Book part
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Treatment of Dystonia , pp. 75 - 78Publisher: Cambridge University PressPrint publication year: 2018
References
Albanese, A, Sorbo, FD, Comella, C, Jinnah, HA, Mink, JW, Post, B, Vidailhet, M, Volkmann, J, Warner, TT, Leentjens, AF, Martinez-Martin, P, Stebbins, GT, Goetz, CG, Schrag, A. 2013. Dystonia rating scales: critique and recommendations. Mov Disord 28(7):874–883.CrossRefGoogle ScholarPubMed
Burke, RE, Fahn, S, Marsden, CD, Bressman, SB, Moskowitz, C, Friedman, J. 1985. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 35(1):73–77.Google Scholar
Cano, SJ, Warner, TT, Linacre, JM, Bhatia, KP, Thompson, AJ, Fitzpatrick, R, Hobart, JC. 2004. Capturing the true burden of dystonia on patients: the cervical dystonia impact profile (CDIP-58). Neurology 63(9):1629–1633.CrossRefGoogle Scholar
Cano, SJ, Hobart, JC, Edwards, M, Fitzpatrick, R, Bhatia, K, Thompson, AJ, Warner, TT. 2006. CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia. Neurology 67(12):2230–2232.CrossRefGoogle ScholarPubMed
Comella, CL, Stebbins, GT, Goetz, CG, Chmura, TA, Bressman, SB, Lang, AE. 1997. Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale. Mov Disord 12(4):570–575.CrossRefGoogle ScholarPubMed
Comella, CL, Leurgans, S, Wuu, J, Stebbins, GT, Chmura, T, Dystonia Study Group. 2003. Rating scales for dystonia: a multicenter assessment. Mov Disord 18(3):303–312.CrossRefGoogle ScholarPubMed
Comella, CL, Fox, SH, Bhatia, KP, Perlmutter, JS, Jinnah, HA, Zurowski, M, McDonald, WM, Marsh, L, Rosen, AR, Waliczek, T, Wright, LJ, Galpern, WR, Stebbins, GT. 2015. Development of the comprehensive cervical dystonia rating scale: methodology. Mov Disord Clin Pract 2(2):135–141.CrossRefGoogle ScholarPubMed
Consky, E, Lang, AE. 1994. Clinical assessments of patients with cervical dystonia. In: Therapy with Botulinum Toxin (Neurological Disease and Therapy). Jankovic, J, Hallett, M, editors. New York: Marcel Dekker.Google Scholar
Defazio, G, Hallett, M, Jinnah, HA, Stebbins, GT, Gigante, AF, Ferrazzano, G, Conte, A, Fabbrini, G, Berardelli, A. 2015. Development and validation of a clinical scale for rating the severity of blepharospasm. Mov Disord 30(4):525–530.CrossRefGoogle ScholarPubMed
Fahn, S. 1989. Assessment of the primary dystonias. In: Quantification of Neurologic Deficit. Munsat, T, editor. London: Butterworths.Google Scholar
Greene, P, Kang, U, Fahn, S, Brin, M, Moskowitz, C, Flaster, E. 1990. Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis. Neurology 40(8):1213–1218.Google Scholar
Jankovic, J, Kenney, C, Grafe, S, Goertelmeyer, R, Comes, G. 2009. Relationship between various clinical outcome assessments in patients with blepharospasm. Mov Disord 24(3):407–413.CrossRefGoogle ScholarPubMed
Jost, WH, Hefter, H, Stenner, A, Reichel, G. 2013. Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapy. J Neural Transm (Vienna) 120(3):487–496.Google Scholar
Lindeboom, R, de Haan, RJ, Aramideh, M, Brans, JW, Speelman, JD. 1996. Treatment outcomes in cervical dystonia: a clinimetric study. Mov Disord 11(4):371–376.CrossRefGoogle ScholarPubMed
Stebbins, GT. 2012. Clinical rating scale development. In: Rating Scales in Parkinson’s Disease: Clinical Practice and Research. Sampaio, C, Goetz, CG, Schrag, A, editors. Oxford: Oxford University Press.Google Scholar
Tarsy, D. 1997. Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin. Mov Disord 12(1):100–102.Google Scholar
Taylor, WJ, Schumacher, HR, Jr, Baraf, HS, Chapman, P, Stamp, L, Doherty, M, McQueen, F, Dalbeth, N, Schlesinger, N, Furst, DE, Vazquez-Mellado, J, Becker, MA, Kavanaugh, A, Louthrenoo, W, Bardin, T, Khanna, D, Simon, LS, Yamanaka, H, Choi, HK, Zeng, X, Strand, V, Grainger, R, Clegg, D, Singh, JA, Diaz-Torne, C, Boers, M, Gow, P, Barskova, VG. 2008. A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout. Ann Rheum Dis 67(6):888–891.CrossRefGoogle ScholarPubMed
Tsui, JK, Eisen, A, Calne, DB. 1988. Botulinum toxin in spasmodic torticollis. Adv Neurol 50:593–597.Google Scholar
Willis, G. 2006. Cognitive interviewing as a tool for improving the informed consent process. J Empir Res Hum Res Ethics 1(1):9–24.CrossRefGoogle ScholarPubMed
Wissel, J, Kabus, C, Wenzel, R, Klepsch, S, Schwarz, U, Nebe, A, Schelosky, L, Scholz, U, Poewe, W. 1996. Botulinum toxin in writer’s cramp: objective response evaluation in 31 patients. J Neurol Neurosurg Psychiatry 61(2):172–175.CrossRefGoogle ScholarPubMed
Zeuner, KE, Peller, M, Knutzen, A, Holler, I, Munchau, A, Hallett, M, Deuschl, G, Siebner, HR. 2007. How to assess motor impairment in writer’s cramp. Mov Disord 22(8):1102–1109.CrossRefGoogle ScholarPubMed
- 1
- Cited by